POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2bex RIBONUCLEASE
INHIBITOR
(Homo
sapiens)		5 / 10LEU A 233
ILE A 262
LEU A 285
LEU A 257
VAL A 222
None
1.20A15.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2wjv REGULATOR OF
NONSENSE TRANSCRIPTS
1
(Homo
sapiens)		5 / 10LEU A 232
VAL A 191
GLU A 178
LEU A 170
VAL A 135
None
1.15A15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2yrl KIAA1837 PROTEIN
(Homo
sapiens)		5 / 10LEU A  17
VAL A  93
TYR A  71
LYS A  44
LEU A  53
None
0.61A24.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		3bdl STAPHYLOCOCCAL
NUCLEASE
DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens)		5 / 10LEU A 586
VAL A 569
ILE A 588
GLU A 562
VAL A 509
None
1.20A15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		3gge PDZ
DOMAIN-CONTAINING
PROTEIN GIPC2
(Homo
sapiens)		5 / 10LEU A 182
VAL A 178
ILE A 165
GLU A 115
LEU A 195
None
1.10A22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		3khf MICROTUBULE-ASSOCIAT
ED
SERINE/THREONINE-PRO
TEIN KINASE 3
(Homo
sapiens)		5 / 10LEU A1023
VAL A1019
ILE A1006
LEU A 997
VAL A 983
None
1.19A20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		4cvh ISOPRENOID SYNTHASE
DOMAIN-CONTAINING
PROTEIN
(Homo
sapiens)		5 / 10LEU A  51
ILE A  93
GLU A 164
LEU A 167
VAL A 162
None
0.93A18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		4i6j F-BOX/LRR-REPEAT
PROTEIN 3
(Homo
sapiens)		5 / 10LEU B 144
ILE B 179
LEU B 200
LEU B 174
VAL B 167
None
1.20A19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		4joc LYSOPHOSPHATIDIC
ACID PHOSPHATASE
TYPE 6
(Homo
sapiens)		5 / 10LEU A 376
ILE A 347
TYR A 378
LEU A 341
VAL A  56
None
1.17A18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		4ol0 TRANSPORTIN-3
(Homo
sapiens)		5 / 10LEU B 353
ILE B 369
LEU B 328
GLU B 325
LEU B 324
None
1.02A11.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		4yc6 CYCLIN-DEPENDENT
KINASE 1
(Homo
sapiens)		5 / 10LEU A  78
VAL A  69
ILE A  52
GLU A  40
LEU A  37
None
1.19A24.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5e6s INTEGRIN ALPHA-L
(Homo
sapiens)		6 / 10LEU A 132
VAL A 233
ILE A 235
TYR A 257
LYS A 287
LEU A 298
None
0.40A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5h64 SERINE/THREONINE-PRO
TEIN KINASE MTOR
(Homo
sapiens)		5 / 10LEU A2508
VAL A2504
ILE A2333
LEU A2201
VAL A2417
None
1.20A5.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5nfn JMJC
DOMAIN-CONTAINING
PROTEIN 7
(Homo
sapiens)		5 / 10LEU A 168
VAL A 128
LEU A 146
LEU A 142
VAL A  76
None
1.19A15.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5oe7 UBIQUITIN
THIOESTERASE OTULIN
(Homo
sapiens)		5 / 10LEU A 332
VAL A 304
ILE A 302
TYR A 319
GLU A 290
None
1.13A20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6f9n CLEAVAGE AND
POLYADENYLATION
SPECIFICITY FACTOR
SUBUNIT 1
(Homo
sapiens)		5 / 10LEU A 963
ILE A 899
GLU A 848
LEU A 864
VAL A 943
None
1.03A19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6f9n CLEAVAGE AND
POLYADENYLATION
SPECIFICITY FACTOR
SUBUNIT 1
(Homo
sapiens)		5 / 10LEU A1182
ILE A1141
TYR A1164
GLU A1098
VAL A1172
None
1.13A19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		1z6t APOPTOTIC PROTEASE
ACTIVATING FACTOR 1
(Homo
sapiens)		4 / 7VAL A 395
LEU A 415
VAL A 411
LEU A 389
None
0.82A16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2yrl KIAA1837 PROTEIN
(Homo
sapiens)		4 / 7LEU A  17
VAL A  93
TYR A  71
LEU A  53
None
0.63A24.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2yrl KIAA1837 PROTEIN
(Homo
sapiens)		4 / 7LEU A  17
VAL A  93
TYR A  71
LYS A  44
None
0.63A24.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		3bpo INTERLEUKIN 13
(Homo
sapiens)		4 / 7VAL A  34
LEU A  28
LEU A  67
LEU A  51
VAL  A  34 ( 0.6A)
LEU  A  28 ( 0.6A)
LEU  A  67 ( 0.6A)
LEU  A  51 ( 0.6A)
0.82A21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		3j0a TOLL-LIKE RECEPTOR 5
(Homo
sapiens)		4 / 7VAL A 790
LEU A 697
LEU A 829
LEU A 832
None
0.86A13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		3t6g SH2
DOMAIN-CONTAINING
PROTEIN 3C
(Homo
sapiens)		4 / 7VAL A 428
LEU A 514
LEU A 654
LEU A 653
None
0.67A19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		4n2c PROTEIN-ARGININE
DEIMINASE TYPE-2
(Homo
sapiens)		4 / 7VAL A 417
LEU A 430
VAL A 460
LEU A 561
None
0.86A14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5ccx TRNA
(ADENINE(58)-N(1))-M
ETHYLTRANSFERASE
NON-CATALYTIC
SUBUNIT TRM6
(Homo
sapiens)		4 / 7VAL B 399
LEU B 423
LEU B 385
LEU B 384
None
0.80A17.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5e6s INTEGRIN ALPHA-L
(Homo
sapiens)		5 / 7LEU A 132
VAL A 233
TYR A 257
LYS A 287
LEU A 298
None
0.47A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5kre LYSOPHOSPHOLIPASE-LI
KE PROTEIN 1
(Homo
sapiens)		4 / 7VAL A 157
LEU A 171
VAL A 144
LEU A 151
None
0.80A19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5mwp MINERALOCORTICOID
RECEPTOR
(Homo
sapiens)		4 / 7VAL A 907
VAL A 739
LEU A 928
LEU A 924
None
0.87A16.57